We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen Announces CE Mark for its Proprietary Multilisa® BICD2 Test

News   Jun 16, 2016

 
Protagen Announces CE Mark for its Proprietary Multilisa® BICD2 Test
 
 
 

RELATED ARTICLES

Uncoupling Obesity from Diabetes

News

About 422 million people around the world, including more than 30 million Americans, have diabetes. Obesity is the most significant risk factor for type 2 diabetes. yet about 30 percent of obese people do not develop type 2 diabetes or other metabolic conditions. New research aims to understand on a cellular level, how this separation occurs.

READ MORE

New Test Helps ID Those at Risk for Five Deadly Diseases

News

Researchers propose that it is time for the biomedical community to consider this genomics approach in clinical care.

READ MORE

Why Do Our Immune Responses Differ?

News

A study of 1,000 individuals has identified three main factors that determine how our immune responses differ. The research might help identify ways to make better vaccines and improve our understanding of autoimmune disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE